Immunic reported 0 in Sales Revenues for its fiscal quarter ending in June of 2024.





Sales Change Date
Alterity Therapeutics Limited AUD 596.04K 584.66K Dec/2025
BioMarin Pharmaceutical USD 990M 224M Jun/2026
Cipla INR 71.19B 5.78B Jun/2026
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 6.35M 60.98M Mar/2026
CSL USD 8.33B 4.79B Dec/2025
Enanta Pharmaceuticals USD 16.96M 50.68M Dec/2024
Grifols EUR 2B 306.7M Mar/2026
Insmed USD 425.49M 119.53M Jun/2026
OraSure Technologies USD 26.76M 322K Dec/2025
Quidel USD 630.9M 10.9M Jun/2026
Ultragenyx Pharmaceutical USD 214M 78M Jun/2026
United Therapeutics USD 783.3M 1.8M Jun/2026